Under construction – not a live service
Sign in
Taking people in ChinaPhase 1

Closed-loop Functional Spinal Cord Stimulation in Patients With Spinal Cord Injury

Key facts

Where
Beijing, ChinaSee the site
Phase
Phase 1

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

Source: NCT04969042, who can take part

Where in China

  • National Engineering Laboratory for NeuromodulationBeijing, ChinaContact: Yang Lu, MDTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Luming Li
Trial code
NCT04969042
Record updated
20 July 2021
Original description
The purpose of this experiment is to evaluate the efficacy of Closed-loop Functional Spinal Cord Stimulation on Walking Rehabilitation in Patients after Spinal Cord InjuryRead full original descriptionShow less

Efficacy of Closed-loop Functional Spinal Cord Stimulation on Walking Rehabilitation in Patients With Spinal Cord Injury

The purpose of this experiment is to evaluate the efficacy of Closed-loop Functional Spinal Cord Stimulation on Walking Rehabilitation in Patients after Spinal Cord Injury

Inclusion: Age 18~70; Spinal cord injury staging(AIS) A,B,C or D; Level of lesion is T10 and above; Distance between lesion and conus >60mm; Injured Time > 3 months; Capable of participating rehabilitation program; Agree to comply with all conditions of the study and to attend all required study training and visits.

Exclusion: Cannot participate in spinal cord stimulation surgery or follow-up visits; With Obvious psychiatric disorder that cannot complete relevant questionaires; Cognitive impairment; Severe autonomic reflex disorder; Abnormal blood or other physiological examinations that cannot conduct surgery, such as blood coagulation disorder or kidney/liver abnormalities; Uncontrollable hypertension, heart diseases, respiratory diseases or took related medicine in last 3 months; Severe muscle atrophy and joint contracture; Life expectancy less than 12 months; Unsuitable candidates in PI's perspective.

ClinicalTrials.gov NCT04969042